Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Otsuka and Lundbeck Published Study Results Showing Aripiprazole 2-Month, Ready-to-Use, Long-Acting Injectable is as Well-Tolerated, and Provides Similar Plasma Levels as Aripiprazole 1-Month for Treatment of Schizophrenia and Bipolar I Disorder | 4 | 354 | April 4, 2023 | |
| Long-acting injectable for schizophrenia approved in the EU | 0 | 175 | April 4, 2024 | |
| European Medicines Agency Commences Review of Aripiprazole 2-Month injectable | 0 | 224 | June 17, 2022 | |
| Aripiprazole IM depot as an option for the treatment of bipolar disorder - | 0 | 217 | April 13, 2021 | |
| FDA OK's 1-Day Initiation for Long-Acting Injectable Schizophrenia Tx | 3 | 508 | July 12, 2018 |